Region: Global
Category: Pharmaceuticals

Global Pharmaceuticals

(23,237 reports matching your criteria)
  • Analgesics

    ... of 5.2% over the analysis period 2023-2030. Prescription Analgesics, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$43.8 Billion by the end of the analysis period. ... Read More

  • Gas Masks

    ... at a CAGR of 7.0% over the analysis period 2023-2030. Disposable Respirators, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$3.8 Billion by the end of ... Read More

  • Generic Drugs

    ... at a CAGR of 6.6% over the analysis period 2023-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of ... Read More

  • Label-Free Detection

    ... at a CAGR of 7.0% over the analysis period 2023-2030. Label-Free Detection Instruments, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.4 Billion by the end ... Read More

  • Home Cleaning Services

    ... by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 11.9% CAGR The Home Cleaning Services market ... Read More

  • Insulin Pumps

    ... at a CAGR of 7.1% over the analysis period 2023-2030. Tethered Pumps, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$15.0 Billion by the end of ... Read More

  • Anti-Obesity Drugs

    ... at a CAGR of 8.7% over the analysis period 2023-2030. Prescription Drugs, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$4.9 Billion by the end of ... Read More

  • Cancer Therapies

    ... at a CAGR of 10.4% over the analysis period 2023-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$112.8 Billion by the end of the ... Read More

  • Animal Feed Additives

    ... by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Amino Acids, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$20.7 Billion by ... Read More

  • Carotid Stents

    ... at a CAGR of 8.7% over the analysis period 2023-2030. Balloon Expandable Stents, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$4.3 Billion by the end ... Read More

  • Antibiotics

    ... of 3.1% over the analysis period 2023-2030. Penicillin, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$15.7 Billion by the end of the analysis period. Growth ... Read More

  • Brachytherapy

    ... of 4.4% over the analysis period 2023-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$1.6 Billion by the end of the ... Read More

  • Computer Aided Engineering (CAE)

    ... reach US$20.6 Billion by 2030, growing at a CAGR of 10.8% over the analysis period 2023-2030. Finite Element Analysis (FEA), one of the segments analyzed in the report, is expected to record a 11.3% CAGR ... Read More

  • Intravenous (IV) Iron Drugs

    ... reach US$4.8 Billion by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Ferric Carboxymaltose, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach ... Read More

  • Human Growth Hormone Drugs

    ... reach US$5.2 Billion by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. Subcutaneous Administration, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach ... Read More

  • Dental Infection Control Products

    ... reach US$2.3 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Dental Infection Control Consumables, one of the segments analyzed in the report, is expected to record a 7.7% CAGR ... Read More

  • OTT Devices and Services

    ... reach US$467.9 Billion by 2030, growing at a CAGR of 17.9% over the analysis period 2023-2030. Video Content, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach ... Read More

  • Lung Cancer Diagnostics

    ... by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Imaging Tests, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.3 Billion by ... Read More

  • Global Enterovirus Vaccine Market Research Report 2024(Status and Outlook)

    ... at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 ... Read More

  • CNS Therapeutics

    ... at a CAGR of 7.2% over the analysis period 2023-2030. Neurodegenerative Diseases Therapeutics, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$75.9 Billion by the end ... Read More

  • Immune Health Supplements

    ... by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Vitamin Ingredients, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$13.1 Billion by ... Read More

  • Disabled and Elderly Assistive Technology

    ... is expected to reach US$41.7 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Communication Aids, one of the segments analyzed in the report, is expected to record a 6.4% ... Read More

  • Automotive Rubber-Molded Components

    ... by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Ethylene Propylene Diene Monomer (EPDM), one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More

  • Active Data Warehousing

    ... by 2030, growing at a CAGR of 9.7% over the analysis period 2023-2030. On-Premise Deployment, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$13.9 Billion by ... Read More

  • Gold Nanoparticles

    ... at a CAGR of 12.5% over the analysis period 2023-2030. Water Soluble Gold Nanoparticles, one of the segments analyzed in the report, is expected to record a 12.5% CAGR and reach US$5.6 Billion by the ... Read More

Cookie Settings